SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-015157
Filing Date
2023-01-25
Accepted
2023-01-25 16:10:56
Documents
12
Period of Report
2023-01-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d441370d8k.htm   iXBRL 8-K 22765
  Complete submission text file 0001193125-23-015157.txt   143995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grtx-20230124.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20230124_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20230124_pre.xml EX-101.PRE 11260
6 EXTRACTED XBRL INSTANCE DOCUMENT d441370d8k_htm.xml XML 3347
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 23552592
SIC: 2834 Pharmaceutical Preparations